EUCTR2008-001704-23-AT进行中（未招募）1 期
Primary hyperparathyroidism: does a systematic treatment improve the calcium and bone metabolism after successful surgery? – Part IISystematic treatment of patients with neither osteopenia nor osteoporosis after successful surgical treatment for primary hyperparathyroidism with Calcium and Vitamin D
Medizinische Universität Wien, Universitätsklinik für Chirurgie0 个研究点目标入组 80 人开始时间: 2009年8月18日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •postmenopausal women
- •male patients
- •biochemically proven PHPT, PTX planned
- •no evidence for osteoporosis or osteopenia (normal BMD)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Cancer (including thyroid or parathyroid cancer)
- •Persisting or recurrent PHPT (postoperative hypercalcemia)
- •Four-gland hyperplasia
- •Multiple endocrine neoplasia (MEN) or hereditary PHPT
- •Familial hypercalcuric hypercalcaemia (Ca/creatinine ratio < 0.01)
- •Phenylketonuria
- •Renal impairment (creatinine clearence <30ml/h)
- •Severe hepatic disorder
- •Severe systemic disorder
- •Thyroid dysfunction
- •Concomittant thyroid surgery
- •Immobilisation
- •Intake of drugs with potential effects on BMD like glucocorticoids, lithium, estrogen-replacement therapy, selective Estrogen-receptor modulators (sERMs), bisphosphonates in the last three months
- •Intake of drugs containing digoxin or digitoxin
- •Known allergy against any component of the study medication
研究者
相似试验
进行中（未招募）
1 期
Primary hyperparathyroidism: does a systematic treatment improve the calcium- and bone metabolism after successful surgery? – Part Systematic treatment of osteopenic and osteoporotic postmenopausal patients after successful surgical treatment for primary hyperparathyroidism with Strontium ranelateOsteopenia or Osteoporosis in postmenopausal womenPrimary hyperparathyroidismMedDRA version: 9.1Level: LLTClassification code 10020707Term: Hyperparathyroidism primaryMedDRA version: 9.1Level: PTClassification code 10031285Term: Osteoporosis postmenopausalEUCTR2008-001703-32-ATMedical University of Vienna60
已完成
不适用
Recurrent/persistent primary hyperparathyroidism, clinical, pathological and genetic aspectshyperactive parathyroid glands10033949primary hyperparathyroidismNL-OMON32114eids Universitair Medisch Centrum30
已完成
不适用
A Retrospective Analysis of the Diagnostic Performance of 11C-choline PET/CT in Primary HyperparathyroidismPrimary Hyperparathyroidism Due to AdenomaPrimary HyperparathyroidismNCT04608253University Medical Center Groningen36
已完成
4 期
Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium RanelateOsteopeniaOsteoporosisPrimary HyperparathyroidismNCT01222026Medical University of Vienna63
已完成
不适用
Asymptomatic Primary Hyperparathyroidism: A Prospective, Randomized TrialPrimary HyperparathyroidismNCT00522028Oslo University Hospital191